Wei Duan

628 total citations
20 papers, 471 citations indexed

About

Wei Duan is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Wei Duan has authored 20 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Wei Duan's work include Drug Transport and Resistance Mechanisms (3 papers), Cervical Cancer and HPV Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Wei Duan is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Cervical Cancer and HPV Research (3 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Wei Duan collaborates with scholars based in China, United States and Australia. Wei Duan's co-authors include Chun Guang Li, Yong Li, Yuan Ming Di, Linlin Wang, Shu‐Feng Zhou, Charlie Changli Xue, Xi-Yong Yu, Jingyuan Wen, Zhi-Wei Zhou and Lin Shu-guang and has published in prestigious journals such as Cancer Research, Nanoscale and Medicine.

In The Last Decade

Wei Duan

16 papers receiving 462 citations

Peers

Countries citing papers authored by Wei Duan

Since Specialization

Citations

This map shows the geographic impact of Wei Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Duan more than expected).

Fields of papers citing papers by Wei Duan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Duan. The network helps show where Wei Duan may publish in the future.

Co-authorship network of co-authors of Wei Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Duan. A scholar is included among the top collaborators of Wei Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Duan. Wei Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Enhancing oxygen evolution reaction performance via Zn/Fe co-doping in a Co ₃ O ₄ nanostructure: mechanistic insights and surface reconstruction dynamics	Materials Horizons	Qianwen Chen, Yanbing Huang et al.	0
2	GLOBE Score and UK‐PBC Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate	Journal of Digestive Diseases	Man Li, Sha Chen et al.	0
3	Clinical Characteristics and Risk Factors of Patients with Lung Cancer Complicated with Pulmonary Embolism: A Case Control Study	Clinical and Applied Thrombosis/Hemostasis	Pengfei Wang, Lei Liang et al.	0
4	Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis	Journal of Digestive Diseases	Sha Chen, Ting Lv et al.	1
5	Abstract CT079: Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial	Cancer Research	Qinglei Gao, Jing Wang et al.	0
6	Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression	Open Life Sciences	Wei Duan et al.	1
7	[Recommendations of APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis].	PubMed	Wei Duan, Xiong Ma et al.	1
8	[Application of double plasma molecular adsorption system in children with acute liver failure].	PubMed	Jie He, Xinping Zhang et al.	5
9	Kikuchi's disease with hemophagocytic lymphohistiocytosis	Medicine	Wei Duan, Zhenghui Xiao et al.	13
10	The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance	Nanoscale	Yuqian Jiang, Wei Duan et al.	15
11	[Present status of diagnosis and treatment of hepatolenticular degeneration].	PubMed	Yi Li, Zixuan Wu et al.	3
12	Study of clinical diagnosis of cervical glandular intraepithelial neoplasia.	PubMed	Shuyu Yang, Wei Duan et al.	1
13	Immunoglobulin G4-related acquired hemophilia: A case report	Experimental and Therapeutic Medicine	Xiaoyan Li, Wei Duan et al.	6
14	Clinical Value of Cold Knife Conization as Conservative Management in Patients With Microinvasive Cervical Squamous Cell Cancer (Stage IA1)	International Journal of Gynecological Cancer	Yue He, Tong Wang et al.	8
15	Morphology Variation and Optical Properties of ZnO Nanostructures Grown Using Bio-Template	Journal of Nanoscience and Nanotechnology	Yan Li, Wei Jiang et al.	1
16	Stability and Nonlinear Optical Properties of ZnO Nanoparticles	Journal of Nanoscience and Nanotechnology	Wei Duan, Limin Dai et al.	1
17	Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-β-arabinofuranosylcytosine	European Journal of Medicinal Chemistry	Boyang Liu, Wei Duan et al.	25
18	Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development	Current Medicinal Chemistry	Shu‐Feng Zhou, Linlin Wang et al.	273
19	Role of P-Glycoprotein in the Intestinal Absorption of Tanshinone IIA, a Major Active Ingredient in the Root of Salvia miltiorrhiza Bunge	Current Drug Metabolism	Xi-Yong Yu, Lin Shu-guang et al.	61
20	Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4	Current Drug Metabolism	Quan Tian, Jing Zhang et al.	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact